Friday, August 02, 2019 10:35:00 AM
A recently promoted stock (1) TiVo Corp. describes itself as a “global leader in media and entertainment products that power consumer entertainment experiences and enable its customers to deepen and further monetize their audience relationships.” It came into inception on April 2016, when TiVo Inc. and Rovi Corp. merged through Rovi’s acquisition TiVo. Rovi’s is no stranger to controversy. In 2015, Christian Keller. Rovi’s vice president of corporate finance was sued by the SEC for insider trading for his dealings with John Gray (2), an equities researcher for a major brokerage firm. Keller and Gray were subsequently charged with conspiracy and securities fraud (3).
Then there are the numerous controversies surrounding Ameriprise Financial Inc. who hold over 8% of TiVo’s common stock (4). In 2018 the SEC charged them with failure to safeguard client assets because of fraudulent acts such as forging client documents and stealing more than $1 million in retail client funds over a four-year period (5). Ameriprise settled the charges for the sum of $4.5 million. This is not the only time Ameriprise has run into legal troubles. A few years ago, Securities America (an Ameriprise unit at the time) sold hundreds of millions of dollars in supposed medical bills receivables belonging to Medical Capital Holdings in what turned out to be Ponzi scheme (6). Medical Holdings when on to spend the money on a yacht and a Hollywood film. Ameriprise had to pay $150 million to settle the problem (7).
(1) http://www.icontact-archive.com/archive?c=925383&f=3061&s=47183&m=2637326&t=5e3aaaa6bc082a73cc05ab3b54e7dfdd61380804ac86e3cf57174cc5d9e72ca4
(2) https://www.sec.gov/litigation/complaints/2015/comp-pr2015-23.pdf
(3) https://patch.com/california/mountainview/rovi-corp-vp-pleads-guilty-insider-trading
(4) https://www.otcmarkets.com/filing/html?id=13225064&guid=bMuIUqF2LQ1lGth
(5) https://www.sec.gov/news/press-release/2018-154
(6) https://www.sec.gov/litigation/litreleases/2009/lr21165.htm
(7) https://www.thinkadvisor.com/2011/04/21/ameriprise-to-pay-150-million-to-settle-securities/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM